These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 1696846
1. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients. Motzer RJ, Geller NL, Bosl GJ. Cancer; 1990 Sep 01; 66(5):857-61. PubMed ID: 1696846 [Abstract] [Full Text] [Related]
2. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. Bosl GJ, Geller NL, Bajorin D, Leitner SP, Yagoda A, Golbey RB, Scher H, Vogelzang NJ, Auman J, Carey R. J Clin Oncol; 1988 Aug 01; 6(8):1231-8. PubMed ID: 2457657 [Abstract] [Full Text] [Related]
3. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. Bosl GJ, Geller NL, Vogelzang NJ, Carey R, Auman J, Whitmore WF, Herr H, Morse M, Sogani P, Chan E. J Clin Oncol; 1987 Mar 01; 5(3):436-40. PubMed ID: 2434627 [Abstract] [Full Text] [Related]
4. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. Wozniak AJ, Samson MK, Shah NT, Crawford ED, Ford CD, Altman SJ, Stephens RL, Natale RB, Bouroncle BA, Blumenstein BA. J Clin Oncol; 1991 Jan 01; 9(1):70-6. PubMed ID: 1702148 [Abstract] [Full Text] [Related]
8. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, Bosl GJ. J Natl Cancer Inst; 1993 Nov 17; 85(22):1828-35. PubMed ID: 7693955 [Abstract] [Full Text] [Related]
9. [A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer]. Iinuma S, Yamamoto H, Hagiwara M, Nakazono M. Gan To Kagaku Ryoho; 1990 Feb 17; 17(2):293-6. PubMed ID: 1689134 [Abstract] [Full Text] [Related]
11. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Broun ER, Nichols CR, Turns M, Williams SD, Loehrer PJ, Roth BJ, Lazarus HM, Einhorn LH. Cancer; 1994 Mar 15; 73(6):1716-20. PubMed ID: 7512438 [Abstract] [Full Text] [Related]
16. [Results of chemotherapy in patients with disseminated testicular tumors]. Abdyldaev TA, Tiuliandin SA, Batov SV. Vopr Onkol; 1990 Jan 01; 36(1):85-9. PubMed ID: 1689527 [Abstract] [Full Text] [Related]
19. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. Motzer RJ, Sheinfeld J, Mazumdar M, Bajorin DF, Bosl GJ, Herr H, Lyn P, Vlamis V. J Clin Oncol; 1995 Nov 01; 13(11):2700-4. PubMed ID: 7595727 [Abstract] [Full Text] [Related]
20. Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood. Hayashi Y, Ohi R, Konno T, Tsuchiya S, Muraosa Y, Yaoita S, Watanabe T. Z Kinderchir; 1989 Aug 01; 44(4):208-12. PubMed ID: 2477963 [Abstract] [Full Text] [Related] Page: [Next] [New Search]